ישראל - עברית - Ministry of Health

genmedix - ketamine as hydrochloride 50 mg/ml - solution for injection - ketamine - as the sole anaesthetic agent for diagnostic and surgical procedures. when used by intravenous or intramuscular injection, ketamine is best suited for short procedures. with additional doses, or by intravenous infusion, ketamine can be used for longer procedures. if skeletal muscle relaxation is desired a muscle relaxant should be used and respiration should be supported. for the induction of anaesthesia prior to the administration of other general anaesthetic agents. to supplement other anaesthetic agents. specific areas of application or types of procedure: when the intramuscular route of administration is preferred. debridement, painful dressings and skin grafting in burned patients as well as other superficial surgical procedures. neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms and lumbar punctures. diagnostic and operative procedures of the eye, ear, nose and mouth including dental extractions.( note: eye movement may persist during ophthalmological procedures). anaes

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - eptifibatide 2 mg/ml - solution for injection - eptifibatide - eptifibatide teva is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-q-wave myocardial infarction. eptifibatide is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (ptca) balloon angioplasty directional atheretomy transluminal extraction catheter atherectomy rotational ablation angioplasty or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death myorardial infarction need for urgent intervention). eptifibatide is intended for use with aspirin and heparin.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 3800 iu / 0.4 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during heamodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 2850 iu / 0.3 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 5700 iu / 0.6 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 7600 iu / 0.8 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

makor medical - אחות - שואב ריר + מוצרים מתכלים

ישראל - עברית - Ministry of Health

dr.samuelov importing & marketing ltd, israel - primula root dry extract (6-7:1); extracting agent : ethanol 47.4 % (v/v); thyme herb dry extract (6-10:1); extracting agent: ethanol 70.0 % (v/v) - טבליות מצופות פילם - primula root dry extract (6-7:1); extracting agent : ethanol 47.4 % (v/v) 60 mg; thyme herb dry extract (6-10:1); extracting agent: ethanol 70.0 % (v/v) 160 mg - combinations

ישראל - עברית - Ministry of Health

dr.samuelov importing & marketing ltd - extract (1:38.5) from 0.011 g of a mixture of gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3);1. extracting agent: ethanol 59 % (v/v), 2. - 4. extracting agent: purified water - סירופ - extract (1:38.5) from 0.011 g of a mixture of gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3);1. extracting agent: ethanol 59 % (v/v), 2. - 4. extracting agent: purified water 417 mg/ml

ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - molds extracts - תמיסה להזרקה - molds extracts - mould fungus and yeast fungus - mould fungus and yeast fungus - skin testing and immunotherapy.